126 related articles for article (PubMed ID: 8423552)
1. Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke.
Thomas GR; Thibodeaux H; Bennett WF; Refino CJ; Badillo JM; Errett CJ; Zivin JA
J Pharmacol Exp Ther; 1993 Jan; 264(1):67-73. PubMed ID: 8423552
[TBL] [Abstract][Full Text] [Related]
2. FK-506 extended the therapeutic time window for thrombolysis without increasing the risk of hemorrhagic transformation in an embolic rat stroke model.
Okubo S; Igarashi H; Kanamatsu T; Hasegawa D; Orima H; Katayama Y
Brain Res; 2007 Apr; 1143():221-7. PubMed ID: 17316578
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
[TBL] [Abstract][Full Text] [Related]
4. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
[TBL] [Abstract][Full Text] [Related]
5. [Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus?].
Kirchhof K; Sikinger M; Welzel T; Zoubaa S; Sartor K
Rofo; 2004 Jan; 176(1):98-105. PubMed ID: 14712413
[TBL] [Abstract][Full Text] [Related]
6. Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: a comparison with free t-PA.
Heeremans JL; Prevost R; Bekkers ME; Los P; Emeis JJ; Kluft C; Crommelin DJ
Thromb Haemost; 1995 Mar; 73(3):488-94. PubMed ID: 7667833
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis.
van Giezen JJ; Boon GI; Jansen JW; Bouma BN
Thromb Haemost; 1993 Apr; 69(4):381-6. PubMed ID: 8497851
[TBL] [Abstract][Full Text] [Related]
8. Small animal thrombosis models for the evaluation of thrombolytic agents.
Stassen JM; Lijnen HR; Kieckens L; Collen D
Circulation; 1991 Jun; 83(6 Suppl):IV65-72. PubMed ID: 2040073
[TBL] [Abstract][Full Text] [Related]
9. Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue-type plasminogen activator in rabbits. Interference of tissue-derived components.
Colucci M; Paramo JA; Stassen JM; Collen D
J Clin Invest; 1986 Jul; 78(1):138-44. PubMed ID: 3088040
[TBL] [Abstract][Full Text] [Related]
10. A long-half-life and fibrin-specific form of tissue plasminogen activator in rabbit models of embolic stroke and peripheral bleeding.
Thomas GR; Thibodeaux H; Errett CJ; Badillo JM; Keyt BA; Refino CJ; Zivin JA; Bennett WF
Stroke; 1994 Oct; 25(10):2072-8; discussion 2078-9. PubMed ID: 8091454
[TBL] [Abstract][Full Text] [Related]
11. Function of tissue-type plasminogen activator releaser on vascular endothelial cells and thrombolysis in vivo.
Ueshima S; Matsuno H; Hayashi M; Horibuchi K; Okada K; Fukao H; Uematsu T; Matsuo O
Thromb Haemost; 2002 Jun; 87(6):1069-74. PubMed ID: 12083488
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of sonothrombolysis in a rat model of embolic ischemic stroke.
Daffertshofer M; Huang Z; Fatar M; Popolo M; Schroeck H; Kuschinsky W; Moskowitz MA; Hennerici MG
Neurosci Lett; 2004 May; 361(1-3):115-9. PubMed ID: 15135907
[TBL] [Abstract][Full Text] [Related]
13. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
Zhang L; Zhang ZG; Ding GL; Jiang Q; Liu X; Meng H; Hozeska A; Zhang C; Li L; Morris D; Zhang RL; Lu M; Chopp M
Circulation; 2005 Nov; 112(22):3486-94. PubMed ID: 16316970
[TBL] [Abstract][Full Text] [Related]
14. A thrombosis model for evaluating thrombolytic agents in the guinea-pig: comparison of t-PA, scu-PA and a novel thrombolytic agent, staphylokinase, on thrombolytic activity.
Hirata Y; Umemura K; Takiguchi Y; Uematsu T; Nakashima M
Blood Coagul Fibrinolysis; 1993 Aug; 4(4):569-75. PubMed ID: 7692999
[TBL] [Abstract][Full Text] [Related]
15. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice.
Chen TY; Lee MY; Chen HY; Kuo YL; Lin SC; Wu TS; Lee EJ
J Pineal Res; 2006 Apr; 40(3):242-50. PubMed ID: 16499561
[TBL] [Abstract][Full Text] [Related]
16. Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro.
Tratar G; Blinc A; Strukelj M; Mikac U; Sersa I
Thromb Haemost; 2004 Mar; 91(3):487-96. PubMed ID: 14983224
[TBL] [Abstract][Full Text] [Related]
17. Limiting systemic plasminogenolysis reduces the bleeding potential for tissue-type plasminogen activators but not for streptokinase.
Thomas GR; Thibodeaux H; Errett CJ; Badillo JM; Wu DT; Refino CJ; Keyt BA; Bennett WF
Thromb Haemost; 1996 Jun; 75(6):915-20. PubMed ID: 8822586
[TBL] [Abstract][Full Text] [Related]
18. Thrombolytic and pharmacokinetic properties of human tissue-type plasminogen activator variants, obtained by deletion and/or duplication of structural/functional domains, in a hamster pulmonary embolism model.
Collen D; Lijnen HR; Vanlinthout I; Kieckens L; Nelles L; Stassen JM
Thromb Haemost; 1991 Feb; 65(2):174-80. PubMed ID: 1905070
[TBL] [Abstract][Full Text] [Related]
19. Acute hypertension promotes hemorrhagic transformation in a rabbit embolic stroke model: effect of labetalol.
Fagan SC; Bowes MP; Lyden PD; Zivin JA
Exp Neurol; 1998 Mar; 150(1):153-8. PubMed ID: 9514832
[TBL] [Abstract][Full Text] [Related]
20. Synergism between tissue-type plasminogen activator and a genetically engineered variant lacking the finger domain, the growth factor domain and the first kringle domain.
Mattson C; Wikström K; Sterky C; Pohl G
Thromb Haemost; 1991 Mar; 65(3):286-90. PubMed ID: 1710837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
